JIC
MDXG icon

Johnson Investment Counsel’s MiMedx Group MDXG Stock Holding History

Johnson Investment Counsel’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-40,961
Closed -$261K – 653
2018
Q2 		$261K Buy
40,961
+960
+2% +$6.83K 0.01% 546
2018
Q1 		$278K Buy
+40,001
New +$466K 0.01% 532

Other funds holding MDXG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
TA
Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Johnson Investment Counsel's MDXG Position: Q3 2018 in Review

Johnson Investment Counsel sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 40,961 shares — an estimated $261K sold.

Johnson Investment Counsel first reported a position in MDXG in Q1 2018 and held it in 2 quarters. The position peaked at $278K in Q1 2018. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

  • Johnson Investment Counsel reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
  • Johnson Investment Counsel sold 40,961 MiMedx Group shares in Q3 2018, an estimated $261K.
  • Johnson Investment Counsel first reported a position in MiMedx Group in Q1 2018 and held it in 2 quarters.
  • Johnson Investment Counsel's MiMedx Group position peaked at $278K in Q1 2018.
  • 186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Johnson Investment Counsel's 13F filing for Q3 2018, filed 14 Nov 2018.